[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361981-105":59,"doc-detail-361981-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","distinct-mitochondrial-dna-deletion-profiles-in-pediatric-band-t-all-during-diagnosis-remission-and-relapse","Distinct Mitochondrial DNA Deletion Profiles in Pediatric Band T-ALL During Diagnosis, Remission, and Relapse","","Mitochondria are central to cellular energy, and while mitochondrial DNA (mtDNA) large deletions are linked to primary mitochondrial disorders, their role in cancer remains unclear. This study examines 148 bone marrow samples from 129 pediatric acute lymphoblastic leukemia patients (B-ALL and T-ALL) at diagnosis, remission, and relapse using long-range PCR, next-generation sequencing, and the Splice-Break2 pipeline. T-ALL and B-ALL showed elevated mtDNA deletions versus controls, with subtype- and timepoint-specific clustering. Large clonal deletions occurred in some B-ALL remission cases, suggesting treatment-driven selection or toxicity. Multivariate analysis identified disease type, timepoint, and WHO subtype as significant determinants of deletion metrics, while age and gender were not associated. Results support mtDNA deletion profiling as a pediatric ALL biomarker and potential indicator of mitochondrial toxicity contributing to late effects in survivors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/distinct-mitochondrial-dna-deletion-profiles-in-pediatric-band-t-all-during-diagnosis-remission-and-relapse/361981/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/distinct-mitochondrial-dna-deletion-profiles-in-pediatric-band-t-all-during-diagnosis-remission-and-relapse/361981.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of analyzing mtDNA deletions in pediatric ALL?","Question",{"text":112,"@type":113},"To determine how mitochondrial DNA deletion profiles vary across disease stages (diagnosis, remission, relapse) and between B-ALL and T-ALL, and to assess whether they could inform disease origins and treatment responses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did mtDNA deletion levels differ between T-ALL, B-ALL, and controls?",{"text":117,"@type":113},"Both ALL subtypes showed significantly more mtDNA deletions than controls; T-ALL had an approximately ~100-fold increase and B-ALL about a ~15-fold increase.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors significantly influenced mtDNA deletion metrics in the study?",{"text":121,"@type":113},"Disease type, timepoint, and WHO subtype significantly affected mtDNA deletion metrics, while age and gender did not show significant influence.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361981,1790291753,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Article  \nDistinct Mitochondrial DNA Deletion Profiles in Pediatric Band T-ALL During Diagnosis, Remission, and Relapse  \nHesamedin Hakimjavadi 1, Elizabeth Eom 2, Eirini Christodoulou 1,3, Brooke E. Hjelm 4, Audrey A. Omidsalar 4, Dejerianne Ostrow 1, Jaclyn A. Biegel 1,5 and Xiaowu Gai 1,5,6, *  \nAcademic Editor: Yumay Chen  \nReceived: 29 June 2025  \nRevised: 17 July 2025  \nAccepted: 19 July 2025  \nPublished: 23 July 2025  \nCitation: Hakimjavadi, H.; Eom, E.; Christodoulou, E.; Hjelm, B.E.; Omidsalar, A.A.; Ostrow, D.; Biegel, J.A.; Gai, X. Distinct Mitochondrial DNA Deletion Profiles in Pediatric Band T-ALL During Diagnosis, Remission, and Relapse. Int. J. Mol. Sci. 2025, 26, 7117. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26157117](doi.org/10.3390/ijms26157117)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA 90027, USA  \n2 Cancer and Blood Disease Institute, Children’s Hospital Los Angeles, Los Angeles, CA 90027, USA  \n3 Department of Pathology, Harvard Medical School, Boston, MA 02115, USA  \n4 Department of Translational Genomics, Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA  \n5 Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA  \n6 Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA  \n* Correspondence: [xgai@mcw.edu](xgai@mcw.edu)  \nAbstract  \nMitochondria are critical for cellular energy, and while large deletions in their genome (mtDNA) are linked to primary mitochondrial diseases, their significance in cancer is less understood. Given cancer’s metabolic nature, investigating mtDNA deletions in tumors at various stages could provide insights into disease origins and treatment responses. In this study, we analyzed 148 bone marrow samples from 129 pediatric patients with B-cell (BALL) and T-cell (T-ALL) acute lymphoblastic leukemia at diagnosis, remission, and relapse using long-range PCR, next-generation sequencing, and the Splice-Break2 pipeline. Both T-ALL and B-ALL exhibited significantly more mtDNA deletions than did the controls, with T-ALL showing a ~100-fold increase and B-ALL a ~15-fold increase. The T-ALL samples also exhibited larger deletions (median size > 2000 bp) and greater heterogeneity, suggesting increased mitochondrial instability. Clustering analysis revealed distinct deletion profiles between ALL subtypes and across disease stages. Notably, large clonal deletions were detected in some B-ALL remission samples, including one affecting up to 88% of mtDNA molecules, which points toward treatment-driven selection or toxicity. A multivariate analysis confirmed that disease type, timepoint, and WHO subtype significantly influenced mtDNA deletion metrics, while age and gender did not. These findings suggest that mtDNA deletion profiling could serve as a biomarker for pediatric ALL and may indicate mitochondrial toxicity contributing to late effects in survivors.  \nKeywords: mitochondrial DNA deletions; pediatric leukemia; acute lymphoblastic leukemia; B-ALL; T-ALL; chemotherapy effects  \n1. Introduction  \nMitochondria are vital organelles that play a crucial role in eukaryotic cell energy production through oxidative phosphorylation [1–4] . Each mitochondrion contains its own 16.6 kb circular genome, the mitochondrial DNA (mtDNA) which encodes proteins for the electron transport chain and other essential functions [5,6] . The biogenesis of mitochondria is a highly intricate process that requires the coordinate","cbCainDerYkUPcfn","https://ap.wps.com/l/cbCainDerYkUPcfn","pdf",8607028,21,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What is the main goal of analyzing mtDNA deletions in pediatric ALL?\",\"answer\":\"To determine how mitochondrial DNA deletion profiles vary across disease stages (diagnosis, remission, relapse) and between B-ALL and T-ALL, and to assess whether they could inform disease origins and treatment responses.\"},{\"question\":\"How did mtDNA deletion levels differ between T-ALL, B-ALL, and controls?\",\"answer\":\"Both ALL subtypes showed significantly more mtDNA deletions than controls; T-ALL had an approximately ~100-fold increase and B-ALL about a ~15-fold increase.\"},{\"question\":\"Which factors significantly influenced mtDNA deletion metrics in the study?\",\"answer\":\"Disease type, timepoint, and WHO subtype significantly affected mtDNA deletion metrics, while age and gender did not show significant influence.\"}]","Distinct Mitochondrial DNA Deletion Profiles in Pediatric Band T-ALL During Diagnosis, Remission, and Relapse | PDF",1790146199,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98bf2d93b1007c07bd6329cee217b9f4.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63b798f40f5830ffc359176a81658bd4.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5221922892dddf66260236bf23e7c331.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebdb5e8cf586846c8d2812bdcc514b7c.webp",980,1385]